A carregar...

Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients

The purpose of this study was to determine the safety of tinzaparin for deep vein thrombosis prophylaxis in newly diagnosed grade III–IV malignant glioma patients. Patients were initiated on daily tinzaparin at a fixed dose of 4,500 IU subcutaneously between 48 h and 4 weeks post-operative for plann...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Perry, Stephanie L., Bohlin, Cindy, Reardon, David A., Desjardins, Annick, Friedman, Allan H., Friedman, Henry S., Vredenburgh, James J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2837514/
https://ncbi.nlm.nih.gov/pubmed/19415455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-009-9911-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!